4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-031005
Chief Financial Officer sold 1,428 shares at $11.22 ($16,022)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2020-05-18 | Sale | −1,428 | $11.22 | $16,022 | 137,375 | D |
| Open-market sales · 1,428 sh · avg $11.22 · $16,022 | |||||||
Loading xslF345X03/doc4.xml…